Sign In
Buy RIGL
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Moderate Buy” from Brokerages
02:13am, Sunday, 29'th Mar 2026
Shares of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, Marke
Rigel Pharmaceuticals: Growing Where It Matters
06:49am, Tuesday, 10'th Mar 2026
Rigel Pharmaceuticals maintains strong sales momentum across its three approved targeted therapies, justifying a continued Buy rating. RIGL trades at a low P/E of ~7 despite robust 2025 revenue growth
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
08:32pm, Tuesday, 03'rd Mar 2026
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates
06:15pm, Tuesday, 03'rd Mar 2026
Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $0.8 per share a year ago.
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
04:01pm, Tuesday, 03'rd Mar 2026
Fourth quarter 2025 total revenues of approximately $69.8 million, including record net product sales of $65.4 million and contract revenues of $4.4 million 2025 total revenues of approximately $294.3
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?
11:01am, Tuesday, 24'th Feb 2026
Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential?
10:05am, Tuesday, 24'th Feb 2026
Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products.
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update
08:05am, Tuesday, 24'th Feb 2026
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its fourth quarter and full year 2025 financial results after
Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026?
09:15am, Wednesday, 18'th Feb 2026
Rigel Pharmaceuticals RIGL had an encouraging year in 2025. The company is yet to report its fourth-quarter and full-year 2025 results, but preliminary figures released last month point to another str
RIGL Stock Rises 59% in a Year: Time to Buy, Hold or Sell?
10:01am, Monday, 16'th Feb 2026
Rigel Pharmaceuticals climbs 59% in a year as Tavalisse anchors growth, oncology gains traction and 2026 guidance points to sustained momentum.
Beacon Harbor Wealth Advisors Inc. Makes New $4.31 Million Investment in Rigel Pharmaceuticals, Inc. $RIGL
04:34am, Thursday, 05'th Feb 2026
Beacon Harbor Wealth Advisors Inc. purchased a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) in the undefined quarter, according to the company in its most recent Form 13F filing with the Se
Rigel Appoints Michael P. Miller to the Board of Directors
08:05am, Tuesday, 03'rd Feb 2026
SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Michael P.
FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside?
12:27pm, Wednesday, 28'th Jan 2026
Amicus and Rigel target rare diseases, but a pending BioMarin buyout and growing drug sales set up different upside paths for investors.
Rigel Pharmaceuticals: Continued Financial Performance, Catalysts In 2026
10:40pm, Monday, 26'th Jan 2026
Rigel Pharmaceuticals has benefitted from Tavalisse's sustained outperformance, driving increasing net income and attractive valuation metrics. Gavreto's recent flat performance is offset by RIGL's ov
Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:25am, Thursday, 15'th Jan 2026
Rigel Pharmaceuticals, Inc. (RIGL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
